Pulmatrix, Inc. (PULM) earnings
PULM earnings moved a median of -0.49% by the close. Quarterly and annual PULM reports and results, each read against the price at its own news timestamp. Back to the PULM overview →
24 measured PULM earnings events.
Where these PULM earnings landedvs 24 measured PULM earnings reactions
| Middle 50% of PULM earnings reactions | -2.03% to +0.58% |
|---|---|
| Median reaction (to close) | -0.49% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 PULM earnings events with a measured close landed between -2.03% and +0.58%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Pulmatrix, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +4.14% | |
| Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger | Press release | +0.00% | +4.14% | |
| Form 10-K/A Pulmatrix, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.67% | |
| Form 10-Q Pulmatrix, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.40% | -0.79% | |
| Pulmatrix Announces First Quarter 2026 Financial Results | Press release | -0.40% | -0.79% | |
| Form 10-K Pulmatrix, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -9.06% | |
| Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results | Press release | +0.00% | -9.06% | |
| Form 10-Q Pulmatrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.50% | -0.21% | |
| Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets | Press release | -1.50% | -0.21% | |
| Form 10-Q Pulmatrix, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.39% | |
| Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets | Press release | +0.00% | -2.39% | |
| Form 10-Q Pulmatrix, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.82% | -0.44% | |
| Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets | Press release | -3.82% | -0.44% | |
| Form 10-K Pulmatrix, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -3.49% | |
| Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets | Press release | — | -3.49% | |
| Form 10-Q Pulmatrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -1.91% | |
| Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | — | -0.54% | |
| Form 10-Q Pulmatrix, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.89% | +7.14% | |
| Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.89% | +7.14% | |
| Form 10-Q Pulmatrix, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.78% | -1.11% | |
| Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +2.78% | -1.11% | |
| Form 10-K Pulmatrix, Inc. For: Dec 31 | SEC filing · Form 10-K | +7.55% | +10.06% | |
| Form 10-Q Pulmatrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.17% | +0.54% | |
| Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | +2.17% | +0.54% |
Keep exploring
More PULM: analyst actions → · SEC filings → · PULM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Axonics, Inc. (AXNX) | 99 | +0.01% | 51% |
| Novo Integrated Sciences, Inc. (NVOS) | 99 | 0.00% | 42% |
| SunLink Health Systems, Inc. (SSY) | 99 | 0.00% | 49% |
| ARNO THERAPEUTICS INC (ARNI) | 98 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.